News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AbbVie (ABBV) Presses Case For Shire Deal In Discreet Roadshow


7/3/2014 6:51:53 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

AbbVie (ABBV.N) Chief Executive Richard Gonzalez has pressed the case for his $46 billion pursuit of drugmaker Shire (SHP.L) in discreet meetings with shareholders in London this week and is now weighing his next move, according to people familiar with the matter.

Shire shareholders who met with Gonzalez said he had reiterated the case for a deal, arguing that AbbVie would create more value from Shire’s assets than the hyperactivity and rare diseases specialist could do on its own.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters

comments powered by Disqus
Reuters
AbbVie
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES